We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > United

News List

MannKind and United Therapeutics NDA for Tyvaso DPI™ Accepted by U.S. FDA americanpharmaceuticalreview
June 18, 2021
MannKind Corporation and United Therapeutics Corporation announced that the U.S. FDA accepted for priority review the New Drug Application (NDA) for Tyvaso DPI™ (inhaled treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and ...
United Therapeutics Announces FDA Acceptance of Trevyent New Drug Application For Review drugs
September 16, 2019
United Therapeutics Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Trevyent® (treprostinil) for the treatment of pulmonary...